Q3 2025 Holdings
Filed 2025-11-13 | 20 holdings | $503.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-03-18) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Protagonist Therapeutics Inc.(PTGX) | COM | 74366E102 | $162.7M | 2,449,183 | 32.3% |
| Nanobiotix S.A.(NBTX) | SPONSORED ADS | 63009J107 | $106.2M | 5,623,816 | 21.1% |
| MeiraGTx Holdings plc(MGTX) | COM | G59665102 | $54.7M | 6,641,064 | 10.8% |
| Rapport Therapeutics, Inc.(RAPP) | COM | 75383L102 | $53.0M | 1,784,517 | 10.5% |
| CVRx, Inc.(CVRX) | COM | 126638105 | $33.1M | 4,103,430 | 6.6% |
| Legend Biotech Corporation(LEGN) | SPONSORED ADS | 52490G102 | $26.6M | 814,586 | 5.3% |
| Contineum Therapeutics Inc.(CTNM) | CL A | 21217B100 | $23.3M | 1,979,173 | 4.6% |
| Procept BioRobotics Corporation(PRCT) | COM | 74276L105 | $12.8M | 357,939 | 2.5% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $8.8M | 748,062 | 1.7% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | COM | 04280A100 | $8.5M | 247,598 | 1.7% |
| Fate Therapeutics, Inc.(FATE) | COM | 31189P102 | $4.3M | 3,379,064 | 0.8% |
| Neumora Therapeutics, Inc.(NMRA) | COM | 640979100 | $3.4M | 1,849,445 | 0.7% |
| Vor Biopharma, Inc.(VOR) | COM | 929033207 | $2.6M | 53,732 | 0.5% |
| Vor Biopharma, Inc.A | COM | 929033108 | $2.6M | 53,732 | 0.5% |
| Rallybio Corporation | COM | 75120L100 | $1.8M | 3,636,363 | 0.4% |
| Lyell Immunopharma Inc.(LYEL)A | COM | 55083R203 | $891.4K | 54,887 | 0.2% |
| Nano-X Imaging Ltd.(NNOX) | ORD SHS | M70700105 | $587.8K | 158,852 | 0.1% |
| Standard BioTools Inc(LAB) | COM | 34385P108 | $405.6K | 311,967 | 0.1% |
| Adicet Bio, Inc.(TORCEUR) | COM | 007002108 | $295.3K | 364,472 | 0.1% |
| BiomX Inc. | COM | 09090D103 | $50.9K | 96,866 | 0.0% |
| Senseonics Holdings, Inc.(SENS1GBP) | COM | 81727U105 | $23.8K | 54,621 | 0.0% |